AGIO
Agios Pharmaceuticals Inc
NASDAQ · Biotechnology
$26.53
-0.04 (-0.15%)
Open$27.03
Previous Close$26.57
Day High$27.43
Day Low$26.50
52W High$46.00
52W Low$22.24
Volume—
Avg Volume957.4K
Market Cap1.55B
P/E Ratio—
EPS$-6.96
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
-59.0% upside
Current
$26.53
$26.53
Target
$10.87
$10.87
$8.41
$10.87 avg
$14.57
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 36.77M | 50.47M | 202.30M |
| Net Income | 678.67M | 838.44M | -11,058,235 |
| Profit Margin | 1,845.9% | 1,753.6% | -5.5% |
| EBITDA | 680.49M | 887.40M | -14,061,341 |
| Free Cash Flow | — | — | -10,472,931 |
| Rev Growth | -27.2% | -27.2% | +1.9% |
| Debt/Equity | — | — | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |